Concentrations bronchiques de l'amikacine administrée en dose unique journalière = Bronchial secretions concentrations of Amikacin administered once dailySANTRE, C; GEORGES, H; BEAUCAIRE, G et al.Médecine et maladies infectieuses. 1993, Vol 23, Num SEP, pp 39-43, issn 0399-077X, NSConference Paper

Amikacin Can Be Added to Blood to Reduce the Fall in Platelet CountXIAOMIAN ZHOU; XIAOLI WU; WEIXIONG DENG et al.American journal of clinical pathology. 2011, Vol 136, Num 4, pp 646-652, issn 0002-9173, 7 p.Article

L'amikacine en dose unique journalière: une large expérience clinique = Once daily dosing amikacin : a wide clinical experienceCHIDIAC, C; BEAUCAIRE, G.Médecine et maladies infectieuses. 1993, Vol 23, Num SEP, pp 75-81, issn 0399-077X, NSConference Paper

Diffusion tissulaire de l'amikacine en dose unique journalière. Données expérimentales = Tissue penetration of Amikacin (AMK) OD vs bid and vs Netilmicin (NTM) OD in rabbitsGERARD, A; LOZNIEWSKY, A; MERLE-MELET, M et al.Médecine et maladies infectieuses. 1993, Vol 23, Num SEP, pp 37-38, issn 0399-077X, NSConference Paper

Etude clinique, bactériologique et pharmacocinétique de l'amikacine en dose unique journalière en oncologie pédiatrique = Clinical bacteriological and pharmacokinetic study of once daily amikacin in children with solid tumorBOUFFET, E; FUHRùANN, C; FRAPPAZ, D et al.Médecine et maladies infectieuses. 1993, Vol 23, Num SEP, pp 55-59, issn 0399-077X, NSConference Paper

L'amikacine en dose unique journalière chez le patient de réanimation = Once daily dosing of amikacin in intensive care unitBEAUCAIRE, G; SANTRE, C.Médecine et maladies infectieuses. 1993, Vol 23, Num SEP, pp 67-74, issn 0399-077X, NSConference Paper

Chemiluminescence determination of amikacin based on the inhibition of the luminol reaction catalyzed by copperRAMOS FERNANDEZ, J. M; BOSQUE-SENDRA, J. M; GARCIA-CAMPANA, A. M et al.Journal of pharmaceutical and biomedical analysis. 2005, Vol 36, Num 5, pp 969-974, issn 0731-7085, 6 p.Article

Development and validation of a novel LC non-derivatization method for the determination of amikacin in pharmaceuticals based on evaporative light scattering detectionGALANAKIS, Evagelia G; MEGOULAS, Nikolaos C; SOLICH, Petr et al.Journal of pharmaceutical and biomedical analysis. 2006, Vol 40, Num 5, pp 1114-1120, issn 0731-7085, 7 p.Article

Expression of the MexXY efflux pump in amikacin-resistant isolates of Pseudomonas aeruginosaISLAM, S; JALAL, S; WRETLIND, B et al.Clinical microbiology and infection. 2004, Vol 10, Num 10, pp 877-883, issn 1198-743X, 7 p.Article

L'amikacine en dose unique journalière dans le traitement probabiliste du patient neutropénique fébrile: justification, efficacité et tolérance = Single daily dose of amikacin in the empiric treatment of febrile episodes in neutropenic patients : rationale, efficacy and toleranceVAN DER AUWERA, P.Médecine et maladies infectieuses. 1993, Vol 23, Num SEP, pp 60-66, issn 0399-077X, NSConference Paper

Administration en dose unique journalière de l'amikacine. Adaptation à la néonatologie pour des enfants traités avant le 3ème jour d'âge postnatal = Once daily administration of amikacin. Adaptation to neonatology for infants less than 3 days of postnatal ageLANGHENDRIES, J. P; BATTISTI, O; BERTRAND, J. M et al.Médecine et maladies infectieuses. 1993, Vol 23, Num SEP, pp 44-54, issn 0399-077X, NSConference Paper

Activity of Amikacin, Ertapenem, Ciprofloxacin and Levofloxacin alone and in Combination against Resistant Nosocomial Pathogens by Time-KillHOSGOR-LIMONCU, M; ERMERTCAN, S; TASLI, H et al.West indian medical journal. 2008, Vol 57, Num 2, pp 106-111, issn 0043-3144, 6 p.Article

LOCALIZATION OF AN AMIKACIN 3'-PHOSPHOTRANSFERASE IN ESCHERICHIA COLIPERLIN MH; LERNER SA.1981; J. BACTERIOL.; ISSN 0021-9193; USA; DA. 1981; VOL. 147; NO 2; PP. 320-325; BIBL. 15 REF.Article

Antibiotics and immunomodulation: effects of cefotaxime, amikacin, nezlocillin, piperacillin and clindamycinROSZKOWSKI, W; KO, H. L; ROSZKOWSKI, K et al.Medical microbiology and immunology. 1985, Vol 173, Num 5, pp 279-289, issn 0300-8584Article

Pharmacokinectics of vancomycin and amikacin in the subeschar tissue fluid in patients with severe burnYANG, Rong-Hua; RONG, Xin-Zhou; HUA RONG et al.Burns. 2009, Vol 35, Num 1, pp 75-79, issn 0305-4179, 5 p.Article

Transdermal delivery of aminoglycosides : Amikacin transport and iontophoretic non-invasive monitoringNICOLI, Sara; SANTI, Patrizia.Journal of controlled release. 2006, Vol 111, Num 1-2, pp 89-94, issn 0168-3659, 6 p.Article

Amikacin alters auditory brainstem conduction time in newbornsPOBLANO, Adrian; BELMONT, Aurora; SOSA, Jesus et al.Journal of perinatal medicine. 2003, Vol 31, Num 3, pp 237-241, issn 0300-5577, 5 p.Article

Adaptation des trousses Emit® nétilmicine et amikacine sur canaux ouverts du Dimension® RXL HM (Dade Behring) = Evaluation of Emit® netilmicin and amikacin assays on Dimension® RXL HM (Dade Behring) open channelsVETELE, F; MANCHON, M; MIALON, A et al.Annales de biologie clinique (Paris). 2002, Vol 60, Num 6, pp 723-730, issn 0003-3898, 8 p.Article

RAPID, SPECIFIC MICROBIOLOGICAL ASSAY FOR AMIKACIN (BB-K8)MARENGO PB; WILKINS J; OVERTURF GD et al.1974; ANTIMICROB. AGENTS CHEMOTHERAPY; U.S.A.; DA. 1974; VOL. 6; NO 4; PP. 498-500; BIBL. 12REF.Article

Guidelines for aminoglycoside use and applicability to geriatric patients = Recommandations de bon usage des aminosides et applicabilité aux patients gériatriquesUHART, M; LEROY, B; MAIRE, P et al.Médecine et maladies infectieuses. 2013, Vol 43, Num 3, pp 118-122, issn 0399-077X, 5 p.Article

Individualised dosing of amikacin in neonates: a pharmacokinetic/pharmacodynamic analysisSHERWIN, Catherine M. T; SVAHN, Sofia; VAN DER LINDEN, Antje et al.European journal of clinical pharmacology. 2009, Vol 65, Num 7, pp 705-713, issn 0031-6970, 9 p.Article

Inhibition of Prostate Efferent Neurotrasmission by AmikacinGARDI, Mario; NIGRO, Filippo; RAGAZZI, Eugenio et al.The Prostate. 2008, Vol 68, Num 12, pp 1330-1335, issn 0270-4137, 6 p.Article

Pharmacocinétique de l'amikacine chez l'adulte: une hétérogénéité qui remet en cause le calcul de la dose basé sur le poids = Amikacin Pharmacokinetics in Adults: a Variability That Question the Dose Calculation Based on WeightBOURGUIGNON, Laurent; GOUTELLE, Sylvain; GERARD, Cécile et al.Thérapie (Paris). 2009, Vol 64, Num 1, pp 47-53, issn 0040-5957, 7 p.Article

Characterization of Nebulized Liposomal Amikacin (Arikace^TM) as a Function of Droplet SizeZHILI LI; YANLING ZHANG; WURTZ, William et al.Journal of aerosol medecine and pulmonary drug delivery. 2008, Vol 21, Num 3, pp 245-253, 9 p.Article

The effect of amikacin and imipenem alone and in combination against an extended-spectrum β-lactamase-producing Klebsiella pneumoniae strainMATHE, Andras; SZABO, Dora; ANDERLIK, Piroska et al.Diagnostic microbiology and infectious disease. 2007, Vol 58, Num 1, pp 105-110, issn 0732-8893, 6 p.Article